Donna Davies | |
|---|---|
| Born | Donna Elizabeth Harrison |
| Alma mater | University of Wales (BSc, PhD) |
| Known for | Synairgen |
| Scientific career | |
| Fields | Lung diseases Epithelial barrier function Innate immunity Tissue engineering[1] |
| Institutions | University of Oxford University of Southampton |
| Thesis | Ribulose 1,5 - bisphosphate carboxylase from microorganisms (1979) |
| Website | www |
Donna Elizabeth Davies (née Harrison) FMedSci is a British biochemist and professor of respiratory cell and molecular biology at the University of Southampton. In 2003, Davies was the co-founder of Synairgen,[2] an interferon-beta drug designed to treat patients with asthma and chronic obstructive pulmonary disease.[3][1]
- ^ a b Donna E. Davies publications indexed by Google Scholar
- ^ "SYNAIRGEN PLC - Overview (free company information from Companies House)". beta.companieshouse.gov.uk.
- ^ Donna E. Davies publications from Europe PubMed Central